Vonoprazan non-inferior to lansoprazole in treating duodenal ulcer and eradicating Helicobacter pylori in Asian patients.

Xiao-Hua Hou Fandong MengJiangbin WangWeihong ShaCheng-Tang ChiuWoo Chul ChungLiqun GuKentarou KudouChui Fung ChongShutian Zhang

Published in: Journal of gastroenterology and hepatology (2022)

Vonoprazan was well tolerated and non-inferior to lansoprazole for duodenal ulcer healing and achieved H. pylori eradication above the clinically meaningful threshold (90%), in non-Japanese Asian patients.

Keyphrases

helicobacter pylori
end stage renal disease
newly diagnosed
ejection fraction
helicobacter pylori infection
chronic kidney disease
peritoneal dialysis
patient reported outcomes